Akebia Therapeutics (AKBA) Change in Accured Expenses (2013 - 2026)
Akebia Therapeutics' Change in Accured Expenses was -$5.44 million in Q2 2026, compared with $16.01 million a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Change in Accured Expenses (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Akebia Therapeutics' Change in Accured Expenses was $26.35 million through Jun 30, 2026, up 28.3% year-over-year; for FY2025, it was $48.53 million.
- Change in Accured Expenses shows a five-year compound annual growth rate of 50.6% (FY2020 to FY2025).
- In earlier years, Change in Accured Expenses was -$12.78 million in FY2024, -$10.02 million in FY2023, -$38.01 million in FY2022 and -$22.08 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Change in Accured Expenses since Q1 2024.
- Per Business Quant data, AKBA's Change in Accured Expenses in the three quarters before Q2 2026 was $2.04 million (Q1 2026), $13.93 million (Q4 2025) and $15.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn | -5.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.44 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | 13.93 Mn |
| Sep 30, 2025 | 15.82 Mn |
| Jun 30, 2025 | 16.01 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 4.88 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | 519,000.00 |
| Mar 31, 2024 | -15.05 Mn |
| Dec 31, 2023 | 3.71 Mn |
| Sep 30, 2023 | 5.65 Mn |
| Jun 30, 2023 | 5.73 Mn |
| Mar 31, 2023 | -25.12 Mn |
| Dec 31, 2022 | -16.47 Mn |
| Sep 30, 2022 | -2.07 Mn |
| Jun 30, 2022 | -26.85 Mn |
| Mar 31, 2022 | 7.39 Mn |
| Dec 31, 2021 | -37.18 Mn |
| Sep 30, 2021 | 30.81 Mn |
API Access
Akebia Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();